Pharvaris to Host Virtual Investor Event on October 23, 2024 [Yahoo! Finance]
Pharvaris N.V. - Ordinary Shares (PHVS)
Company Research
Source: Yahoo! Finance
click here. Presenters of the event are: Michael E. Manning, M.D., Allergy, Asthma & Immunology Associates, LTD Raffi Tachdjian, M.D., MPH, David Geffen School of Medicine at the University of California, Los Angeles (UCLA) Berndt Modig, Chief Executive Officer of Pharvaris Peng Lu, M.D., Ph.D., Chief Medical Officer of Pharvaris Wim Souverijns, Ph.D., Chief Commercial Officer of Pharvaris A live question and answer session will follow the formal presentations. Following the live event, an archived replay will be available for at least 30 days after the event. About Pharvaris Pharvaris is a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically proven therapeutic target with novel small molecules, the Pharvaris team aspires to offer people with all types of bradykinin-mediated angioedema effective, well-tolerated, and easy-to-administer alternatives to trea
Show less
Read more
Impact Snapshot
Event Time:
PHVS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PHVS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PHVS alerts
High impacting Pharvaris N.V. - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
PHVS
News
- Pharvaris Reports Third Quarter 2024 Financial Results and Highlights Recent Business UpdatesGlobeNewswire
- Pharvaris to Participate in the Guggenheim Healthcare Innovation Conference [Yahoo! Finance]Yahoo! Finance
- Pharvaris to Participate in the Guggenheim Healthcare Innovation ConferenceGlobeNewswire
- Pharvaris Presents Clinical and Non-Clinical Data Supporting HAE Development Program at the 2024 ACAAI Annual Scientific MeetingGlobeNewswire
- Pharvaris Announces Data Highlighting Deucrictibant for the Treatment of HAE to be Presented at Upcoming Scientific MeetingsGlobeNewswire
PHVS
Earnings
- 11/13/24 - Miss
PHVS
Sec Filings
- 11/13/24 - Form 6-K
- 10/31/24 - Form 144
- 10/24/24 - Form 144
- PHVS's page on the SEC website